Bulletin
Investor Alert
×

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210324360/composite

$

82.04

Change

0.00 0.00%

Volume

Volume 24,703

Sep 18, 2019, 5:44 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210324360/composite

Today's close

$ 80.99

$ 82.04

Change

+1.05 +1.30%

Day low

Day high

$80.41

$82.27

Open
Open: 81.14

52 week low

52 week high

$48.26

$99.25

Open

Market cap

$4.17B

Average volume

646,441

P/E ratio

146.29

Rev. per Employee

$354,073

EPS

0.56

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    7:28 a.m. July 13, 2019

    - Philip van Doorn

  2. Repligen started at overweight with $42 stock price target at J.P. Morgan

    8:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  3. Repligen stock fair value estimate raised to $47 from $42 at Janney

    11:26 a.m. June 23, 2017

    - Tomi Kilgore

  4. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    7:01 a.m. June 23, 2017

    - Tomi Kilgore

  5. Repligen's stock halted for news pending

    6:58 a.m. June 23, 2017

    - Tomi Kilgore

  6. Repligen's stock was inactive premarket prior to trading halt

    6:59 a.m. June 23, 2017

    - Tomi Kilgore

  7. Investing From the Ground Up

    12:13 a.m. Sept. 15, 2016

    - Barron's Online

  8. Why Danaher’s Purchase of Pall Means More M&A is on the Way

    11:39 a.m. May 13, 2015

    - Barrons Blogs

  9. Bull trend absorbs soft second-quarter start

    10:41 a.m. April 6, 2015

    - Michael Ashbaugh

  10. These are the most profitable Nasdaq biotech companies

    12:36 p.m. March 2, 2015

    - Philip van Doorn

  11. Here are the best-performing stocks so far in 2015

    12:47 p.m. Jan. 9, 2015

    - Philip van Doorn

  12. 13D Filings

    7:45 a.m. July 27, 2013

    - Barron's Online

  13. 13D Filings

    4:25 a.m. July 20, 2013

    - Barron's Online

  14. Repligen Corp. up 11.5% in premarket

    8:42 a.m. Jan. 2, 2013

    - Steve Gelsi

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. Repligen Corp (RGEN) CEO Anthony Hunt Sold $996,546 of Shares

    6:15 p.m. Sept. 11, 2019

    - GuruFocus.com

  2. Rebalance moves companies among MidCap, SmallCap indexes

    5:47 p.m. Sept. 6, 2019

    - Seeking Alpha

  3. Stephens sees 48% upside in Cerus in premarket analyst action

    7:17 a.m. Aug. 23, 2019

    - Seeking Alpha

  4. Repligen Corp (RGEN) Gets a Buy Rating from H.C. Wainwright

    7:38 a.m. Aug. 12, 2019

    - SmarterAnalyst

  5. The Most Expensive Stocks In The Market: August 2019

    11:11 a.m. Aug. 8, 2019

    - Seeking Alpha

  6. Blueprint Medicines (BPMC) Q2 Loss Widens, Sales Top Mark

    11:54 a.m. Aug. 2, 2019

    - Zacks.com

  7. Acorda (ACOR) Q2 Earnings and Revenues Surpass Estimates

    10:53 a.m. Aug. 2, 2019

    - Zacks.com

  8. 10-Q: REPLIGEN CORP

    4:45 p.m. Aug. 1, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  9. Agios' (AGIO) Loss Widens in Q2, Tibsovo Drives Sales

    12:02 p.m. Aug. 1, 2019

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  1. Hollow Fiber Membrane Market is Worth US$3 Bn By 2026

    6:07 a.m. Sept. 11, 2019

    - Global QYResearch

  2. Global Perfusion Systems Market 2019-

    12:45 a.m. Sept. 9, 2019

    - Eon Market Research

  3. Protein A Resins Market to Soar at steady CAGR up to 2024

    11:36 a.m. Sept. 6, 2019

    - AmericaNewsHour

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.